Study of Low Molecular Weight Heparins

NCT06020560 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

65000

Enrollment

OTHER

Sponsor class

Conditions

Anticoagulant
Venous Thromboembolism
Prophylaxis
Treatment

Interventions

DRUG: Dalteparin Prefilled Syringe
DRUG: Tinzaparin profiled syringe

Sponsor

Herlev Hospital